January 27, 2021
A small group of investors in the company formerly known as Valeant Pharmaceuticals International Inc. waited too long to bring securities fraud claims against the company, a former federal judge in New Jersey said Tuesday.
June 01, 2020
Bausch Health Cos. Inc. and its brass on Friday sought to shed a securities fraud lawsuit that alleges the company engaged in a price-gouging scheme that cost investors billions, telling a New Jersey federal judge that investors' claims came too late.
February 28, 2020
Bausch Health Cos. Inc. was hit with a securities fraud suit in New Jersey federal court Friday from companies managed by hedge fund Maverick Capital alleging that the business, then known as Valeant Pharmaceuticals International Inc., engaged in a price-gouging scheme that cost investors billions.